Literature DB >> 3768642

A comparative study of Ro 03-8799: racemic mixture and enantiomers.

H F Newman, E P Dunphy, N M Bleehen, S Dische, M I Saunders, C Des Rochers, P Workman, I Lenox-Smith, C E Smithen.   

Abstract

The maximum single dose of the 2-nitroimidazole hypoxic cell radiosensitiser Ro 03-8799 is limited to 1 g/m2 by the occurrence of a well characterised acute syndrome of sweating, nausea and mental changes. In an attempt to increase the tolerable dose, the clinical toxicity of the racemic mixture was compared with that of the R- and S-enantiomers of Ro 03-8799. Twelve patients received escalating alternate doses of racemic mixture and R- or S-enantiomer, the dose levels being 0.25 g/m2, 0.5 g/m2, 0.75 g/m2 and 1.0 g/m2. Careful monitoring of the acute syndrome failed to demonstrate any consistent differences between racemic mixture and either enantiomer. This would suggest that the toxicity is not mediated via any specific central nervous system receptor. It is concluded that separation of Ro 03-8799 into its enantiomers will not enable a clinically useful increase in dosage.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3768642     DOI: 10.1259/0007-1285-59-706-997

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  1 in total

1.  Lack of stereoselectivity in the pharmacokinetics and metabolism of the radiosensitizer Ro 03-8799 in man.

Authors:  P Workman; H F Newman; N M Bleehen; R Ward; C E Smithen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.